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Cln3 Activates G1-Specific Transcription via
Phosphorylation of the SBF Bound Repressor Whi5
fall into the G1-specific gene family (Cho et al., 1998;
Spellman et al., 1998). Together, they govern the events
associated with cell cycle initiation, including DNA repli-
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cation, bud morphogenesis, and duplication of spindle1Department of Molecular Biology
pole bodies and thereby impact most subsequent2Department of Cell Biology
events of the cell cycle.The Scripps Research Institute
Expression of G1-specific genes depends upon the10550 North Torrey Pines Road
heterodimeric transcription factors SBF and MBF, eachLa Jolla, California 92037
comprised of Swi6 and a sequence-specific DNA bind-
ing protein, Swi4 or Mbp1, respectively (Breeden, 2003).
Binding of those transcription factors to one or moreSummary
cognate sequences in the promoters of G1-specific
genes is essential for the proper temporal pattern ofG1-specific transcriptional activation by Cln3/CDK ini-
transcription. Consequently, inactivation of Mbp1 andtiates the budding yeast cell cycle. To identify targets
Swi4 leads to loss of viability and arrest during G1 phaseof Cln3/CDK, we analyzed the SBF and MBF transcrip-
(Koch et al., 1993). However, neither Swi4 nor Mbp1tion factor complexes by multidimensional protein in-
alone is essential. Nevertheless, there are distinct differ-teraction technology (MudPIT). Whi5 was identified as
ences in the patterns of gene expression in the individuala stably bound component of SBF but not MBF. Inacti-
mutants (Costanzo et al., 2003; Koch et al., 1993), con-vation of Whi5 leads to premature expression of G1-
sistent with the distribution of MBF and SBF bindingspecific genes and budding, whereas overexpression
sites among G1-specific genes (Iyer et al., 2001; Simonretards those processes. Whi5 inactivation bypasses
et al., 2001; Spellman et al., 1998). Finally, SBF and MBFthe requirement for Cln3 both for transcriptional acti-
appear to be subject to differential regulation (Amon etvation and cell cycle initiation. Whi5 associates with
al., 1993; Costanzo et al., 2003). Nevertheless, the twoG1-specific promoters via SBF during early G1 phase,
factors do show limited functional overlap under somethen dissociates coincident with transcriptional acti-
conditions (Flick et al., 1998; Partridge et al., 1997).vation. Dissociation of Whi5 is promoted by Cln3
Despite their well-established roles in G1-specificin vivo. Cln/CDK phosphorylation of Whi5 in vitro pro-
transcription, binding of SBF and MBF is insufficient formotes its dissociation from SBF complexes. Mutation
transcriptional activation (Cosma et al., 2001; Harringtonof putative CDK phosphorylation sites, at least five of
and Andrews, 1996; Koch et al., 1993). Instead, efficientwhich are phosphorylated in vivo, strongly reduces
and timely transcriptional activation requires the G1SBF-dependent transcription and delays cell cycle ini-
cyclin Cln3 (Dirick et al., 1995; Stuart and Wittenberg,tiation. Like mammalian Rb, Whi5 is a G1-specific tran-
1995; Tyers et al., 1993) and its cognate cyclin-depen-scriptional repressor antagonized by CDK.
dent protein kinase (CDK), Cdc28 (Koch et al., 1996;
Marini and Reed, 1992). Activation of the Cln3/CDK pro-
Introduction motes the formation of the RNA polymerase II holoen-
zyme at the basal promoters of SBF and MBF bound
In budding yeast, as in most cells of metazoan organ- genes and thereby transcriptional activation (Cosma et
isms, cell proliferation is regulated during late G1 phase al., 2001).
in response to a variety of environmental and internal Consistent with its role in G1-specific transcription,
conditions (reviewed by Wittenberg and Flick [2003]). Cln3 is a dose-dependent activator of cell cycle initiation
Preconditions must be met prior to initiation of a new (Cross, 1988; Nash et al., 1988; Tyers et al., 1993). Inacti-
cell cycle. In budding yeast, failure to satisfy those crite- vation of CLN3 causes a dramatic cell size increase,
ria can lead to aberrant or incomplete cell cycle events whereas additional copies of CLN3 promote budding
(Mendenhall and Hodge, 1998). In metazoans, the loss at progressively smaller cell size. Those effects result
of control over cell cycle initiation can, in addition, lead largely from its effect on G1-specific transcription (Dirick
to errors in development, proliferative diseases, and ulti- et al., 1995; Stuart and Wittenberg, 1995; Tyers et al.,
mately death (reviewed by Ho and Dowdy [2002]). 1993) exerted via SBF and MBF (Wijnen et al., 2002). In
The temporally controlled accumulation of families of the most extreme case, hyperstabilization of Cln3 leads
genes encoding components of the cellular machinery not only to an dramatic decrease in the cell size required
required for subsequent events ensures that their func- for budding and entry into S phase but also to resistance
tions are implemented during the appropriate interval. to mating pheromone-induced G1 arrest (Cross, 1988;
In fact, the transcriptional activation of G1-specific Nash et al., 1988). Although CLN3 is expressed through-
genes is the earliest indicator of cell cycle initiation, out the cell cycle, expression is maximal as cells enter
often referred to as Start (reviewed by Breeden [2003] G1 phase (MacKay et al., 2001; McInerny et al., 1997).
and Wittenberg and Flick [2003]). More than 200 genes Cln3 protein levels are low and highly sensitive to
changes in the nutritional and protein-synthetic capacity
to cells (Gallego et al., 1997; Polymenis and Schmidt,*Correspondence: curtw@scripps.edu
1997). Because of the tight coupling between Cln3 abun-3Present address: Chemical Sciences Division, Oak Ridge National
Laboratory, P.O. Box 2008, Oak Ridge, Tennessee 37831. dance and its synthesis rate and because transcriptional
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activation is highly sensitive to Cln3 level, it is well suited
as a sensor of cell growth.
Despite the requirement for Cln3 for timely activation
of G1-specific genes, it is not absolutely required for
expression of those genes or for cell viability. However,
it becomes essential in the absence of CLN1 and CLN2
(Richardson et al., 1989), G1-specific genes encoding
G1 cyclins, or BCK2 (Di Como et al., 1995; Epstein and
Cross, 1994). BCK2 also becomes essential in cells lack-
ing SWI4 or SWI6 (Wijnen and Futcher, 1999). CLN1 and
CLN2 are sufficient for transcriptional activation when
CLN3 is inactive (Dirick et al., 1995; Stuart and Witten-
berg, 1995; Tyers et al., 1993). The mechanism by which
Bck2 promotes transcription and cell cycle initiation is
unclear, but it appears to be at least partially indepen-
dent of SBF and MBF. Despite its apparent redundancy
with Cln3 and Swi6, Bck2 plays a relatively modest role
in their presence.
The mechanism of transcriptional activation via Cln3/
CDK has yet to be established. Although both Swi4 and
Swi6 are phosphorylated in a cell cycle-dependent man-
ner at CDK consensus phosphorylation sites, those sites
appear not to be required for transcriptional activation
(Koch et al., 1996; Sidorova et al., 1995; Wijnen et al.,
2002). Furthermore, Cln3/CDK appears not to bind di-
rectly to SBF or MBF or to promoters of target genes
(Wijnen et al., 2002; K. Flick and C.W., unpublished data).
This has led to the suggestion that one or more regula-
tory factors intervene between the G1 cyclin/CDK and
the G1-specific transcription factors. A similar system
has been well established in metazoans, in which the
tumor suppressor Rb represses E2F-dependent tran-
scription during G1 phase but is then inactivated via
phosphorylation by cyclin D/Cdk4, leading to the activa-
tion of genes required for entry into S phase (reviewed by
Dyson [1998] and Nevins [2001]). In fact, that mammalian
regulatory cascade has been reconstructed at least in
part in yeast cells (Hatakeyama et al., 1994).
In the interest of identifying putative targets of the
Cln3/CDK, we have isolated and characterized compo-
nents of the SBF transcription factor complex. Among
the proteins forming a complex with SBF was Whi5,
identified in genomic screens for mutants that result in
an abnormally small cell size (Jorgensen et al., 2002;
Zhang et al., 2002). We show here that Whi5 associates
with the promoter bound SBF transcription factor to
repress transcription. Furthermore, Cln3 antagonizes
binding of Whi5 to SBF-responsive promoters and its
activity as a transcriptional repressor. We suggest that
Whi5, like Rb, represses G1-specific transcription duringFigure 1. Whi5 Is a Component of SBF
early G1 phase and thereby restrains cell cycle initiation(A) TAP of SBF and/or MBF components (arrows: Swi6, Swi4 and/
or Mbp1) plus additional unknown proteins (arrows) as detected and cell proliferation until it is inactivated by G1 cyclin-
by silver staining of TAP SBF/MBF purified samples separated by dependent protein kinase.
SDS-PAGE.
(B) Whi5 associates specifically with Swi6 and Swi4. Bars represent
number of spectra of proteolytic peptides having a mass consistent
with peptides predicted for Swi6, Swi4, Mbp1, or Whi5 as identified (D) Whi5 does not interact with Mbp1. Extracts were prepared from
by MudPIT analysis. All samples were normalized to the common wild-type strains carrying MBP1-3xHA, WHI5-13xmyc, or both. Anti-
component, Swi6, taking into consideration both number of spectra HA (HA-IP) and anti-myc (myc-IP) immune complexes from asyn-
and protein size. chronous cultures were probed with anti-myc to detect Whi5-
(C) Whi5 interacts with SBF. Extracts were prepared from wild-type 13xmyc or with anti-HA to detect Mbp1-3xHA.
or swi6 strains carrying WHI5-TAP together with SWI4-6xmyc. Anti- (E) Whi5 associates specifically with Swi6 and Swi4. The number of
TAP (IgG-IP) and anti-myc (myc-IP) immune complexes from asyn- spectra representing known SBF and MBF components obtained
chronous cultures were probed with PAP to detect Whi5-TAP or from the MudPIT analysis of Whi5-TAP was normalized to Swi6
with anti-myc to detect Swi4-6xmyc. (based upon both spectra number and protein size).
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Results
Identification of Components of SBF and MBF
To identify potential targets of Cln3/CDK required for
activation of G1-specific transcription, we sought to de-
fine components of the SBF and MBF transcription fac-
tors from cells that were either arrested in G1 phase
prior to transcriptional activation or released into late
G1 phase, during which G1-specific transcription is
maximally activated. To achieve this, Swi4, Swi6, and
Mbp1, the known components of the G1-specific tran-
scription factors, were tagged at the carboxyterminus
with the tandem affinity purification (TAP) epitope at
their genomic loci in a cln1 cln2 strain carrying CLN3
under control of the GAL1 promoter as its only source of
G1 cyclin. Cells expressing each of the epitope-tagged
transcription factor subunits were either arrested during
G1 phase by depletion of Cln3 on raffinose or released
from G1 phase arrest for 20 min (the predetermined
interval required for maximal transcriptional activation)
by addition of galactose and protein complexes purified
by TAP (Rigaut et al., 1999). Silver-stained SDS-PAGE
of the TAP-purified fractions shows that each contains,
in addition to the epitope-tagged component, the ex-
pected SBF or MBF components plus additional un-
known copurified proteins (Figure 1A).
Identification of the components of the transcription
factor complexes was accomplished using the mass
spectrometry-based multidimensional protein interac-
tion technology (MudPIT; Wolters et al., 2001), resulting
in the identification of each of the expected SBF and
MBF components (Swi6, Swi4, and/or Mbp1; Figure 1B)
along with several components that, to our knowledge,
are novel. Those components were classified as SBF
specific (Swi4 and Swi6 fractions), MBF specific (Mbp1
and Swi6 fractions), Swi4 specific, or Mbp1 specific. No Figure 2. Cell Size Analysis of Whi5 Mutants
Swi6-specific interactors were identified. Unexpectedly, The cell volume distribution (fl) of log phase cultures of each of the
indicated strains grown in YEPD (except as indicated) was deter-all but one of those interactors detected in this screen
mined using a Coulter Z2 Particle Analyzer. (A) Small cell size ofoccur with comparable confidence in cells having active
whi5 depends upon SBF. (B) Overexpression of WHI5 increasesor inactive SBF/MBF (data not shown).
cell size. Cells were grown in galactose to induce GAL-WHI5. (C)Two previously studied proteins, Stb1 and Whi5, were
The size increase resulting from cln3 is suppressed by whi5.
shown to interact predominantly with MBF or specifi-
cally with SBF, respectively. Stb1 has been reported to
be an MBF-specific transcriptional activator (Costanzo 6xmyc (Figure 1C) but not with Mbp1-3xHA (Figure 1D).
et al., 2003). Whi5 was identified with the highest confi- To determine whether Whi5 interacts with the intact
dence of any component in SBF complexes other than SBF complex or with Swi6 or Swi4 independently, we
the known subunits Swi4 and Swi6 (Figure 1B), based repeated the immunoprecipitation in strains carrying a
upon both peptide sequence coverage and spectral deletion mutant of the untagged SBF component. We
quality. In contrast, Whi5 was not identified in any of observed that inactivation of either SWI6 or SWI4 abol-
the Mbp1-containing complexes analyzed. Surprisingly, ishes the interaction between Whi5 and the remaining
despite prior analysis of SBF complexes, an interaction SBF component (Figure 1C and data not shown). Finally,
with Whi5 had not been reported (Gavin and Superti- analysis of Whi5-TAP complexes by MudPIT resulted
Furga, 2003; Ho et al., 2002). in the identification of both Swi6 and Swi4 with high
confidence, whereas Mbp1 was not detected (Figure
1E). Together, these data establish that Whi5 is a compo-Whi5 Is a Component of SBF
To confirm the specific interaction of Whi5 with SBF nent of SBF.
detected by MudPIT, we evaluated the interaction of those
proteins by coimmunoprecipitation (coIP). Immune com- Whi5 Inhibits SBF-Dependent
G1-Specific Transcriptionplexes containing TAP-tagged Whi5 also contained
Myc-tagged Swi6 (data not shown) and Myc-tagged WHI5 (YOR083w) was identified previously based upon
the small cell size caused by a null mutation (JorgensenSwi4 (Figure 1C), whereas no Mbp1-HA was detected
(Figure 1D). Accordingly, Whi5-TAP coimmunoprecipi- et al., 2002). Further analysis suggested that Whi5 might
act as an inhibitor of G1-specific transcription. We findtated with Swi6-6xmyc (data not shown) and Swi4-
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that whi5 results in a dramatic reduction in cell size in
both wild-type (Figure 2A) and mbp1 mutant strains
(data not shown) but does not affect the size of swi4
mutants (Figure 2A), consistent with the hypothesis that
Whi5 negatively regulates SBF but not MBF. Further-
more, as expected, expression of GAL1-WHI5 results in
an increase in cell size in otherwise wild-type cells (Fig-
ure 2B) but has little or no effect on swi4 mutants,
which are already large (data not shown). Together,
these observations suggest that the inhibitory effect of
Whi5 is exerted exclusively via SBF. In fact, simply inte-
grating a second allele of WHI5 in tandem with the wild-
type allele results in a significant increase in cell size
(data not shown), suggesting that WHI5 acts as a dose-
dependent inhibitor of Start, much like CLN3 acts as a
dose-dependent activator (Wijnen et al., 2002).
Cln3 Acts via Whi5 to Promote Cell Cycle Initiation
To evaluate whether Cln3 antagonizes Whi5 activity, we
compared the cell size of asynchronous populations of
whi5 and cln3 mutants to cln3 whi5 mutants (Fig-
ure 2C). Inactivation of Whi5 was not only sufficient to
suppress the increase in cell size caused by inactivation
of Cln3 but resulted in a cell size distribution identical
to that caused by whi5. This epistasis relationship sug-
gests that Cln3 acts via Whi5 to regulate cell cycle initi-
ation.
To eliminate the potential contributions to cell size of
cell cycle defects outside of G1 phase, we evaluated the
critical cell size (cell volume) at which bud emergence
occurs in small G1 daughter cells isolated by centrifugal
elutriation. Previous analysis has shown critical cell size
at budding to be directly related to the activation of G1-
specific transcription and to be a sensitive assay for the
G1-specific function of Cln3 (Dirick et al., 1995; Stuart
and Wittenberg, 1995). Small G1 daughter cells were
isolated from asynchronous populations of wild-type
and whi5 strains by centrifugal elutriation and allowed
to progress through the cell cycle. Whereas wild-type
cells budded at 35 fl, whi5 resulted in a dramatic
reduction in the cell size required for budding (20 fl;
Figure 3A, top panel). In fact, isolation of the smallest
cells from the asynchronous population failed to yield
greater than 80% unbudded cells, many of which bud-
ded within the first 20 min of growth. We conclude that
the whi5 mutation results in a dramatic advancement
of Start and that a large fraction of the small G1 daughter
cells in the whi5 population have already executed
Start prior to abscission from the mother cell.
To more precisely establish the relationship betweenFigure 3. Cln3 Acts via Whi5 to Activate SBF-Dependent Cell Cy-
cle Initiation Whi5 and Cln3, we determined the effect of whi5 on
(A) whi5mutants progress through Start independent of Cln3. (Top the timing of cell cycle initiation in cln3 mutants. As
panel) Small unbudded cells were isolated by centrifugal elutriation, shown previously, cln3 mutants bud at almost twice
inoculated into fresh medium, and allowed to progress synchro- the size of wild-type cells (60 fl; Figure 3A, top panel)
nously through the cell cycle. Cell size and budding index were
(Cross, 1988; Nash et al., 1988), consistent with the de-determined at 20 intervals. (Bottom panel) CLN2 RNA levels were
pendency upon Cln3 for cell cycle initiation during G1determined in the synchronized cells by RT-PCR. The transcript
phase. Strikingly, cln3 whi5 double mutants bud atlevels are expressed as the fold increase relative to the lowest
level observed in the wild-type time course after normalization of
all values to the ACT1 RNA level in the same samples.
(B) Comparison of CLN2 and CDC20 RNA levels in wild-type and
whi5 mutants. CDC20 RNA levels were determined in the synchro- (C) whi5 bypasses the lethality caused by bck2 cln3. (Left panel)
nized cells by RT-PCR and plotted along with the data for CLN2 Growth of the indicated strain carrying YCpCLN3::URA3 under se-
RNA presented in the bottom panel of (A). Lines and symbols used lective conditions. (Right panel) Growth of the same strains on 5-FOA
are consistent with those used in (A). to select against the YCpCLN3::URA3 plasmid.
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a comparable size to whi5 mutants (20 fl; Figure 3A, MBP1 (Figure 3C). While bck2 cln3 whi5 mbp1
mutants are able to proliferate in the absence oftop panel). As with whi5mutants, it is difficult to isolate
a pure unbudded population. Both of these observations YEpURA3-CLN3, bck2 cln3whi5 swi4mutants are
not. Thus, bypass of the lethality of bck2 cln3mutantsdemonstrate that whi5 is epistatic to cln3, suggesting
a pathway in which Cln3 exerts its positive effect on depends upon the activity of SBF. Consistent with this
finding, the level of CLN2 gene expression in an asyn-cell cycle initiation by antagonizing the negative effect
of Whi5. chronous population of bck2 cln3 whi5 mutants is
comparable to that observed in wild-type cells, whereas
expression is negligible in a bck2 cln3 (GAL1-CLN3)Whi5 Represses G1-Specific Transcriptional
strain grown on glucose (data not shown). In contrast,Activation Upstream of SBF
we find that inactivation of WHI5 is insufficient to supportThe early initiation of budding, as observed in whi5
the viability of either bck2 swi6 GAL1-CLN2 or cln1mutants, often reflects premature activation of G1-spe-
cln2 cln3 GAL1-CLN3 strains in the presence of glu-cific transcription. To evaluate SBF-dependent transcrip-
cose (data not shown). These data provide additionaltion, we measured the level of transcripts from CLN2,
support for the SBF-specific role of Whi5 and, morea well-characterized SBF-dependent gene (Figure 3A,
importantly, show that inactivation of WHI5 abolishesbottom panel). The level of the CLN2 transcript in wild-
the requirement for the G1-specific transcriptional acti-type cells peaks at 35 fl, corresponding with bud emer-
vators CLN3 and BCK2.gence, and is subsequently rapidly lost, presumably due
to transcriptional inactivation associated with cell cycle
progression (Amon et al., 1993). In contrast, the CLN2 Whi5 Binds via SBF to Promoters
transcript is high in the smallest whi5 mutant cells of Transcriptionally Inactive G1-Specific Genes
and, as observed in wild-type cells, rapidly decreases The identification of Whi5 as an SBF bound inhibitor
as budding increases to the maximum level. We believe of transcriptional activation suggests that it may act
this unexpected behavior to be a consequence of our directly at the level of SBF-dependent promoters. Bind-
failure to isolate a whi5population in which the majority ing of epitope-tagged Swi4, Swi6, and Whi5 to two G1-
of cells are pre-Start and, therefore, undergoing tran- specific promoters, CLN2 (SBF specific) and CLB5 (MBF
scriptional activation of G1-specific genes. Consistent specific), and the HXT3 promoter (SBF/MBF indepen-
with that interpretation, the inactivation of G1-specific dent) was assessed by ChIP analysis. Like Swi4 (Cosma
transcription observed during the first cell cycle in the et al., 2001; Cross et al., 1994; Koch et al., 1996), Whi5
whi5 population is followed by the accumulation of binds to the CLN2 promoter (Figure 4A) and only weakly,
the CDC20 transcript (solid gray line, Figure 3B), which or not at all, to the CLB5 promoter. As previously demon-
accumulates only after cells have passed Start and en- strated, Swi6 binds efficiently to both of the CLN2 and
tered the budded phase of the cell cycle in wild-type CLB5 promoters (Harrington and Andrews, 1996; Koch
cells (dashed gray line, Figure 3C) (Spellman et al., 1998). et al., 1996), whereas none of those proteins binds de-
CDC20 expression decreases when a second peak of tectably to the HXT3 promoter (Figure 4A and data not
accumulation of the CLN2 transcript is observed. shown). Binding of Whi5 to the CLN2 promoter is not
Consistent with its effect on the minimal cell size at observed in a swi4 strain (Figure 4B), and, as predicted,
budding, inactivation of CLN3 in wild-type cells results that binding is independent of Mbp1. We conclude that
in a dramatic delay in transcriptional induction of CLN2 Whi5 binds to G1-specific promoters via SBF.
(Figure 3A, bottom panel). Analysis of the CLN2 tran- To evaluate the relationship between Whi5 binding to
script in a whi5 cln3 double mutant revealed that, like SBF-dependent promoters and G1-specific transcrip-
bud emergence, CLN2 expression is coincident with that tional activation, we analyzed timing of Whi5 binding to
observed in the strain carrying whi5 alone (Figure 3A, the promoters of three SBF targets, CLN2, CLN1, and
bottom panel). PCL1, by ChIP analysis following release from G1 phase
Together, these findings demonstrate that inactiva- arrest by mating pheromone. We find that, like Swi6,
tion of whi5 bypasses the requirement for Cln3 for Whi5 is bound to the CLN2 promoter in mating phero-
SBF-dependent transcriptional activation. We conclude mone-arrested cells. However, in contrast to Swi6, it
that Whi5 delays G1-specific transcriptional activation dissociates just prior to transcriptional activation (Figure
and thereby cell cycle initiation and that Cln3 antago- 4C, upper panel). As indicated by Swi6 binding, SBF
nizes that inhibition. remains associated with the CLN2 promoter until cells
enter the budded phase of the cell cycle and transcrip-
tion is inactivated (Figure 4C, lower panel). A similarInactivation of Whi5 Bypasses the Lethality
of bck2 cln3 Mutants pattern of Whi5 binding was observed at the CLN1 and
PCL1 promoters. Thus, association of Whi5 with SBF-Because inactivation of WHI5 was sufficient to bypass
the requirement for CLN3 for activation of SBF-depen- dependent promoters early in G1 phase correlates with
transcriptional repression, and its subsequent dissocia-dent transcription, we sought to determine whether it
could also bypass the lethality resulting from bck2 tion correlates with Cln3/CDK-dependent G1-specific
transcriptional activation.cln3 (Figure 3C). Whereas a bck2 cln3 mutant is
unable to survive under conditions that select for loss We evaluated whether Cln3 was sufficient for dissoci-
ation from SBF-dependent promoters or whether addi-of the YEpURA3-CLN3 plasmid, the bck2 cln3 whi5
mutant remains viable following loss of that plasmid. To tional cyclins were required. Binding of Whi5 to the same
three promoters was evaluated by chromatin immuno-determine whether SBF, MBF, or both are required for
that bypass, we evaluated the requirement for SWI4 and precipitation in cells that lack CLN3, express CLN3 as
Cell
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Figure 4. Whi5 Hyperphosphorylation Correlates with Disassociation of Whi5 from SBF Bound to Transcriptionally Active G1-Specific Gene Pro-
moters
(A) Whi5 binds to CLN2 promoter DNA. Chromatin immunoprecipitation of CLN2 (SBF dependent), CLB5 (MBF dependent), and HXT3 (SBF/
MBF independent) promoter DNA by Swi4-myc and Whi5-myc immunoprecipitation. Immunoprecipitation from a strain containing no epitope-
tagged genes is presented as a negative control.
(B) Whi5 binds CLN2 promoter via SBF. Chromatin immunoprecipitation of CLN2 and CLB5 promoter DNA from a wild-type (wt), mbp1, or
swi4 strain by Whi5-myc immunoprecipitation.
(C) Whi5 disassociation from CLN2 promoter correlates with transcription activation of SBF-dependent promoters. (Top panel) Chromatin
immunoprecipitation of the CLN2 promoter DNA by Swi6-myc and of CLN1, CLN2, and PCL1 promoter DNA by Whi5-myc from cells arrested
by  factor (0) or released from the arrest for the indicated interval (10–60). (Bottom panel) Budding index and CLN2 RNA levels in cells
from the same time course.
(D) Slower-migrating form of Whi5 accumulates during late G1 phase. Western blot analysis of Whi5 protein from samples taken during the
 factor arrest and release time course shown in (C).
(E) Whi5 disassociation from SBF-dependent promoters is Cln3 dependent. (Top panel) Chromatin immunoprecipitation of CLN2, CLN1, and
PCL1 promoter DNA by Whi5-myc immunoprecipitation from cln1 cln2xs CLN3, CLN1 CLN2 cln3, and cln1 cln2xs cln3 TRP1::GAL1-
CLN3 (cln-less) strains during  factor arrest and release in glucose-containing medium. (Bottom panel) Budding index and CLN2 RNA levels
in the same samples.
(F) Whi5 binds SBF throughout the cell cycle. Coimmunoprecipitation of Swi6-myc in Whi5-TAP immunecomplexes from asynchronous cells
(As) or following  factor arrest (0) and release for the indicated intervals (20 and 60).
their only G1 cyclin, or express no G1 cyclins. As pre- transcription (Figure 4E). In cells lacking G1 cyclins,
CLN2 expression remained repressed, and Whi5 re-dicted, a decrease in the binding of Whi5 to all three
promoters correlated with the activation of G1-specific mained bound to the CLN2 promoter. In cells having
Cln3 Activates SBF by Inactivating Whi5
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only CLN3 (Figure 4E), the rapid activation of CLN2 ex-
pression following release from arrest was coordinate
with the dissociation of Whi5 from each of the SBF-
dependent promoters, as observed in wild-type cells.
In contrast, cells lacking CLN3 only activated CLN2 ex-
pression after a significant delay and did so more gradu-
ally than either wild-type or cln1 cln2 cells. Consistent
with the pattern of expression, a marked decrease in the
extent and rate of dissociation of Whi5 was observed.
Whereas dissociation appears rapid and concerted in
the wild-type strain (Figure 4C), the decrease is more
gradual in the cln1 cln2 strain (Figure 4E), suggesting
a contribution of other G1 cyclins. Nevertheless, CLN1
and CLN2 are insufficient in the absence of CLN3, since
Whi5 appears to remain bound in that strain until late
in the time course. Together, these data strongly sug-
gest that transcriptional activation via Cln3 is exerted
via its capacity to antagonize Whi5 binding to G1-spe-
cific promoters.
Whereas the dissociation of Whi5 from SBF bound
promoters at the time of transcriptional activation is
consistent with its behavior as a transcriptional repres-
sor of SBF-dependent genes, it does not explain the
results of our MudPIT analysis that shows that Whi5
is present in a complex with SBF from cells actively
transcribing CLN2. To address this issue, we analyzed
Whi5 binding to Swi6 in synchronized cells by coimmu-
noprecipitation (Figure 4F). Whi5 was found in a complex
with Swi6 even subsequent to the dissociation of both
proteins from promoters. We conclude that Whi5 forms
a complex with SBF independent of its binding to G1-
specific promoters.
Whi5 Hyperphosphorylation Is Associated
with G1-Specific Transcriptional Activation
Our data suggest that Whi5 might be a direct target
for phosphorylation by Cln3-associated CDK. Several
minor species of reduced mobility are apparent in HA-
tagged Whi5 from asynchronous cells (Figure 5A). Con-
sistent with their identity as phosphorylated species,
treatment of immune complexes containing Whi5-HA with
lambda phosphatase resulted in conversion of those spe-
(C) Whi5 is a target of cyclin-dependent kinase Cdc28 in vitro. (Left
panel) Full-length Whi5-13xmyc prepared under denaturing condi-
tions was used as a substrate for phosphorylation by purified Cdc28-
Figure 5. Phosphorylation of Whi5 by G1 Cyclin-Dependent Kinase TAP complexes from asynchronous cells (As) and cdc34-3 mutant
Cdc28 Promotes Disassociation from SBF In Vitro cells synchronized during late G1 phase by release from an  factor
(A) Whi5 is hypo- and hyperphosphorylated in vivo. Western blot arrest at the restrictive temperature (37C) for 60 min (late G1).
analysis of Whi5-HA and Cln2-HA in whole cell extract (total) or Arrows indicate phosphorylated Whi5-myc species. The mobility of
following immunoprecipitation and treatment with lambda phospha- the full-size Whi5-13xmyc protein and a degradation product (*) is
tase in the presence or absence of phosphatase inhibitors. Arrows indicated. (Right panel) Protein kinase activity of purified soluble
indicate dephosphorylated, hypophosphorylated (*), and hyper- Cdc28 CDK was determined using histone H1 as a substrate. His-
phosphorylated (**) protein migration. tone H1 (1 g) was used in each kinase assay. The exposure shown
(B) Phosphorylation of Whi5 by various forms of the Cdc28 CDK. for histone H1 is 1/100 of that shown for Whi5.
Extracts were prepared from cdc34-3 or cdc34-3 cln1 cln2xs (D) Whi5 disassociates from SBF complex when phosphorylated by
strains expressing Whi5-13xmyc. Cells were either arrested during cyclin-dependent kinase Cdc28. Calmodulin beads containing TAP-
G1 by  factor arrest, arrested during late G1 by cdc34-3 at the purified SBF prepared from cells expressing Swi4-TAP and Whi5-
restricted temperature (37C) for 180 min, or grown at the permissive 13xmyc and arrested during G1 by  factor were treated with soluble
temperature (25C) for 180 min after release from  factor arrest to purified Cdc28 CDK complexes from either asynchronous cells (As)
allow progression out of G1 phase. Arrows indicate different mobility or late G1 cells as indicated in (C). Following treatment, the calmodu-
forms of Whi5-13xmyc protein. Signal in the CLN1 CLN2 CLN3 lanes lin bead bound fraction (B) or the fraction released into the superna-
at 37C and 25C was digitally enhanced to facilitate the visualization tant (S) were analyzed by immunoblotting with anti-myc antibody.
of the differing mobility. Arrows indicate different mobility forms of Whi5-13xmyc protein.
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cies to a single species of higher mobility than those ob- expressing untagged Whi5 or when no Cdc28 CDK was
added. Thus, Whi5 is a substrate of the Cdc28 CDKserved in untreated samples or in samples treated with
phosphatase in the presence of phosphatase inhibitors. in vitro. This agrees with a recent study (Ubersax et al.,
2003), in which Whi5 was detected among the buddingThe well-characterized phosphoprotein Cln2 is provided
as a positive control (Lanker et al., 1996). yeast proteins that are directly phosphorylated by the
Cdc28 CDK in vitro.To determine the relationship between phosphoryla-
tion of Whi5 and its disassociation from G1-specific To evaluate whether phosphorylation by the Cdc28
CDK promotes dissociation of Whi5 from SBF in vitro,promoters, we examined the mobility of the Whi5 protein
in the same population of synchronized cells used for we prepared SBF complexes containing Whi5-myc by
purification of Swi4-TAP from cells arrested during G1the ChIP analysis of Swi6 (Figure 4D). Whereas Whi5-
TAP migrates as a single species during early G1 phase by depletion of G1 cyclins. The Whi5-SBF complexes
retained on calmodulin beads were treated with either(Figure 4C), a slower-migrating form of Whi5-TAP ap-
pears and becomes increasingly apparent as cells pro- Cln-CDK complexes or Cdc28 CDK from asynchronous
cells (Figure 5D). In both cases, Whi5-myc was phos-gress into the budded phase of the cell cycle. Phospha-
tase treatment of Whi5-TAP demonstrates that, like the phorylated and released into the supernatant, whereas
it was retained on the beads in the untreated samples.Whi5-HA protein shown in Figure 5A, even the highest-
mobility species is phosphorylated (data not shown). We conclude that Cln-CDK-dependent phosphorylation
is sufficient to promote dissociation of Whi5 from SBF,We conclude that Whi5 is phosphorylated at one or more
positions during all cell cycle phases but that a portion consistent with the timing of its dissociation from pro-
moters in vivo.of that protein becomes hyperphosphorylated as cells
progress through G1 phase.
To establish the form of the CDK responsible for Whi5 Phosphorylation of Whi5 Determines the Timing
phosphorylation, we compared the mobility of Whi5 in of SBF-Dependent Transcriptional Activation
cells in which specific cyclins accumulate. Whereas all and Cell Cycle Progression
three G1 cyclins accumulate in a cdc34-ts strain arrested Whi5 contains four perfect CDK consensus sites (S/T-
during late G1 phase at the restrictive temperature, a P-X-K/R; sites 1, 2, 11, and 12) and eight minimal con-
cln1 cln2 cdc34-ts strain accumulates only Cln3. sensus sequences (S/T-P; sites 3–10; Figure 6A). Analy-
B-type cyclins fail to accumulate due to the inability of sis of TAP-purified Whi5 obtained from transcriptionally
cdc34 mutants to degrade the Clb/CDK inhibitor Sic1 active G1 phase cells by mass spectrometry revealed
(Schwob and Nasmyth, 1993). Those strains were ar- the presence of phosphopeptides representing five pu-
rested in late G1 phase by shifting to the restrictive tative CDK sites (sites 2, 4, 5, 10, and 12; data not
temperature for 3 hr, and the electrophoretic mobility shown). We mutated the phosphoacceptor amino acid
of Whi5 was compared to Whi5 from the same cells at those sites, along with two other sites (sites 8 and
either arrested by  factor to inactivate all forms of the 9), to alanine. Surprisingly, we were unable to introduce
CDK or allowed to progress into G2/M phase (Figure the mutant gene (designated WHI57A) under control of
5B). That analysis revealed that, whereas Cln3/CDK pro- the endogenous WHI5 promoter into cells, either alone
motes only a small shift in mobility, the accumulation of or in tandem with a wild-type copy of the gene. The
all three G1 cyclins results in more extensive retardation, basis for that lethality has not been established. To obvi-
similar to that observed at the permissive temperature ate that problem, the mutant and wild-type open reading
where B-type cyclin-associated forms of the CDK accu- frame were placed under control of the conditional MET3
mulate. These data suggest that Cln3/CDK promotes promoter and integrated into the genome of whi5 mu-
quantitative phosphorylation of Whi5, then leads to pro- tant cells. As expected, both strains exhibited the small
gressively greater phosphorylation by Cln1- and Cln2- cell size phenotype of the whi5 mutant when grown
associated CDK and then by Clb/CDK. This is consistent on methinonine-containing medium (Met) to repress
with the effect of Cln3 activity on Whi5 binding to G1 MET3-dependent transcription. Although cells express-
specific promoters and with the finding that dissociation ing either MET3-WHI5 or MET3-WHI57A became larger
of Whi5 from those promoters is less concerted in the than wild-type cells after the shift to methionine-defi-
absence of CLN1 and CLN2 (Figure 4E). cient medium (Met) for several generations, the in-
crease in cell size observed in the strain expressing
WHI57A was substantially greater (data not shown). Anal-Whi5 Phosphorylation by Cdc28 Kinase
Promotes Dissociation from SBF In Vitro ysis of Whi5-myc expressed from the MET3 promoter
revealed that the level of expression of both Whi5 andWe evaluated whether Whi5 could act as a target for
the Cdc28 CDK in vitro. TAP-tagged Cdc28 was purified Whi57A was comparable to that expressed from the en-
dogenous promoter (Figure 6B). This suggests that thefrom either asynchronous cells or cells expressing only
G1 cyclins (cdc34-ts mutants arrested following release effect of expression of MET3-WHI5 might result from
misregulation of WHI5 expression rather than from over-from  factor arrest). Both preparations of Cdc28 CDK
kinase were active against histone H1 and immunopre- expression.
To evaluate the importance of phosphorylation duringcipitated 13xmyc-tagged Whi5 (Figure 5C). Based upon
their relative kinase activity, measured using histone H1 G1 phase, cells expressing either MET3-WHI5 or MET3-
WHI57A were pregrown in Met medium and shiftedas a substrate, the Cln-associated CDK appeared to be
more efficient than the total CDK at phosphorylating to Met medium to induce the MET3 promoter, and
then small cells were isolated by centrifugal elutriationWhi5. No phosphorylation of Whi5 was observed when
the immune complexes were prepared from a strain and evaluated for cell size, G1-specific gene expression,
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and budding (Figure 6C). As expected, both the timing
and extent of transcriptional activation and budding ob-
served in the MET-WHI5 strain were comparable to wild-
type cells. In contrast, the MET-WHI57A mutant budded
at a substantially larger cell size, and the expression of
the SBF-dependent CLN2 transcript was delayed and
reduced relative to that in cells expressing wild-type
WHI5. Consistent with the specificity of Whi5 for SBF,
the MBF-dependent transcript RNR1 was expressed at
a comparable level to cells expressing mutant or wild-
type WHI5. Finally, the lower-mobility phosphorylated
forms of Whi5 observed following release from  factor
arrest in wild-type cells (Figure 4D) and cells expressing
MET-WHI5-myc fail to accumulate in the MET-WHI57A-
myc mutant (data not shown). We conclude that phos-
phorylation of Whi5 at one or more sites affected by the
CDK site mutations is required for efficient and timely
activation of SBF-dependent genes.
Discussion
We have shown that Whi5 interacts specifically with SBF
but not independently with either of its known subunits
or MBF. Whi5 binds to SBF at G1-specific promoters
and acts as a repressor of G1-specific transcriptional
activation. As cells progress into late G1 phase, Whi5
dissociates from promoters in a Cln3-dependent man-
ner (Figure 7A). Dissociation is promoted by and depen-
dent upon Cln3 in vivo and is promoted by Cln/CDK
in vitro. Consistent with its behavior as an in vitro sub-
strate for the Cdc28 CDK, mass spectrometric analysis
of Whi5 demonstrates that it is phosphorylated in vivo
at CDK consensus sites during late G1 phase (data not
shown). Mutational analysis of a subset of the putative
CDK sites in Whi5 demonstrates that Whi5 phosphoryla-
tion is required for efficient transcriptional activation of
SBF-dependent genes and, consequently, for timely cell
cycle initiation.
Whi5 is not simply required to keep SBF-dependent
gene expression low outside of G1 phase but acts as a
component of the mechanism governing periodic tran-
scription. The pattern and extent of transcriptional acti-
vation of CLN2 in whi5 and cln3whi5 mutants is
substituted with alanine (A).
(B) Whi5 protein expressed from the inducible MET3 promoter accu-
mulates to a similar level to wild-type Whi5. Western blot analysis
of Whi5 protein isolated from asynchronous cells expressing WHI5
from the endogenous promoter or WHI5 or WHI57A from the MET3
promoter under repressing (Met) or inducing (Met) conditions.
Cdc28 is presented as loading control.
(C) Mutation of CDK phosphorylation sites in Whi5 delays cell cycle
initiation and reduces and delays SBF-dependent transcriptional
activation. Cells were grown inMet medium for 25 prior to centrif-
ugal elutriation to induce WHI5 and WHI57A transcription. Small un-
budded cells were isolated by centrifugal elutriation, inoculated into
fresh Met medium, and allowed to progress synchronously
through the cell cycle. (Top panel) Cell size, budding index and RNA
levels were determined at 20 intervals. (Middle panel) RNR1 RNA
Figure 6. Whi5 Phosphorylation at CDK Consensus Sites Is Re- levels determined in the synchronized cells by RT-PCR. (Bottom
quired for Efficient Transcriptional Activation of SBF-Dependent panel) CLN2 RNA levels determined by RT-PCR. The transcript lev-
Genes and, Consequently, for Timely Cell Cycle Initiation els are presented as a percentage relative to the highest level ob-
served in both time courses after normalization of all values to the(A) Putative CDK phosphorylation sites in Whi5. CDK sites are shown
ACT1 RNA level in the same samples.in gray. Sites mutated in this study are indicated by the amino acid
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that assumption into question. In fact, there is evidence
that transcriptional repression of SBF- and MBF-depen-
dent genes subsequent to Start occurs via distinct
mechanisms (Amon et al., 1993). A recent study shows
that Stb1, an established Swi6 binding protein, specifi-
cally affects MBF-dependent transcriptional activation
(Costanzo et al., 2003). Although it was found to specifi-
cally associate with MBF in that study, we identified Stb1
with a high degree of confidence by MudPIT analysis
in both SBF- and MBF-containing samples (data not
shown). Preliminary analysis is consistent with a role for
Stb1 in addition to its role in MBF-dependent transcrip-
Figure 7. Model for Regulation of G1-Specific Transcriptional in tion (data not shown). However, its importance in wild-
Yeast and Mammalian Cells
type cells and whether that role is SBF dependent are
(A) Cln3-dependent CDK phosphorylates Whi5, releasing SBF from unclear.
negative regulation. Activation of SBF-dependent genes promotes
Additional factors found by MudPIT analysis to inter-S phase entry and leads to expression of CLN1 and CLN2. Accumla-
act specifically with SBF, MBF, Swi4, and Mbp1 aretion of Cln1-2/CDK further phosphorylates Whi5.
(B) Cyclin D/CDK phosphorylates Rb, releasing E2F from negative currently under investigation. Preliminary data show that
regulation. Activation of E2F-responsive genes promotes S phase several of the SBF/MBF interactors have an effect on
entry and leads to expression of cyclin E. Accumulation of cyclin cell size either when inactivated or overexpressed, con-
E/CDK further phosphorylates Rb, contributing to the activation of sistent with effects on SBF- and MBF-dependent tran-
E2F-responsive genes.
scription. Efforts are underway to unravel the biological
significance of those interactions.
The existence of an inhibitor of G1-specific transcrip-indistinguishable, arguing that CLN3 plays no role in
tion that is antagonized by Cln3/CDK has been hypothe-SBF-dependent transcription under those conditions in
sized based upon analogy of metazoan Rb. The identifi-the absence of Whi5. Whi5 is not necessary for repres-
cation of Whi5 as such an inhibitor shows yet againsion of transcription outside of G1 phase. Overexpres-
that there is a close functional homology between thesion of Whi5 or elimination of CDK phosphorylation sites
regulatory components involved in G1-specific tran-leads to large cell size and delayed transcriptional acti-
scriptional activation in yeast and mammalian cells. Thevation, whereas inactivation of Whi5 leads to small cell
similarities between Whi5 and Rb are striking (Figuresize and early transcription. Thus, inactivation of Whi5
7). In mammalian cells, passage through the restrictionis both necessary and sufficient for activation of tran-
point and entry into S phase is determined at least inscription and therefore is sufficient to explain the re-
part by the phosphorylation of Rb by cyclin D-Cdk4/quirement for CLN3. Timely dissociation of Whi5 from
Cdk6 and subsequently cyclin E-Cdk2 (reviewed by Ste-SBF-dependent promoters depends upon CLN3 and is
vens and La Thangue [2003]). In yeast, phosphorylationcoincident with transcriptional activation.
of Whi5 by Cln3/CDK, and possibly subsequently byWhi5 persists outside of G1 phase and is found in
Cln1-2/CDK, leads to transcriptional activation of SBF-association with SBF subsequent to SBF disassociation
responsive genes promoting passage through Start, thefrom promoters. Whether these complexes fail to asso-
primary gating event of the yeast cell cycle. Cln3 andciate with promoters due to their state of modification,
Cln1/2 have been equated to mammalian cyclin D1 andtheir localization, alterations in their composition, or
cyclin E, respectively (Hatakeyama et al., 1994). Further-other properties remains to be established. However,
more, like the effect of Whi5 on G1-specific transcriptionthe presence of Whi5, whether free or in a complex with
factors in yeast, the effect of Rb association with E2FSBF, places it in a position to play roles beyond its
is only one of several pathways regulating E2F activity.activity at promoters. For example, Whi5 may regulate
It is clear that resolution of the seemingly complex net-localization of SBF or its assembly or association with
work of transcriptional regulators involved in G1-spe-promoters. Those additional functions might explain the
cific gene regulation and, more generally, in cell cycle-effect of overexpression of Whi5 and perhaps even the
dependent regulation of gene expression in both yeastlethality of the WHI57A mutant under the endogenous
and metazoans remains a major goal.promoter.
Although inactivation of Whi5 occurs at the time of
Experimental Procedurestranscriptional activation of SBF-dependent genes and
is sufficient for activation, additional mechanisms are
Strains and DNAscertainly involved in the regulation of SBF-dependent
All yeast strains used in this study were derived from 15Daub (MATa
and, more generally, G1-specfic transcription. Both SBF ade1 leu2-3,112 his2 trp1-1 ura3ns bar1). The table of yeast stains
and MBF are targets for CDK-dependent phosphoryla- used is presented in Supplemental Data (see Table S1 at http://
www.cell.com/cgi/content/full/117/7/887/DC1). TAP strategy wastion and, as such, are likely targets of regulatory mecha-
carried out in CWY 747 (15Daub TRP1::GAL1-CLN3 cln1 cln2nisms that overlap with or perhaps act in concert with
cln3 pep4::LEU2). The strategy of Rigaut et al. (1999) was used todissociation of Whi5 from the SBF complex. Because
append a TAP tag to SWI6, SWI4, MBP1, WHI5 (carboxyterminus),MBF- and SBF-dependent transcription are cocoordi-
and CDC28 (aminoterminus) at their endogenous loci. The PCR-
nately regulated, it has been assumed that this occurs based gene disruption method of Reid et al. (2002) was used to
via a conserved mechanism, likely involving the shared create the cln3 bck2 bypass strain. The PCR method of Longtine
et al. (1998) was used to disrupt WHI5, SWI4, and SWI6, GAL1component Swi6. The specificity of Whi5 for SBF calls
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promoter integrate, and 3xHA, 13xmyc, or 11xmyc tag at the car- Other Methods
Cell size analysis was performed using a Coulter Z2 Particle Cellboxyterminus WHI5. 6xmyc-tagged alleles of SWI4 and SWI6; dis-
ruption of PEP4, MBP1, and SWI4; 3xHA tagging of MBP1; and Analyzer (Beckman-Coulter). Cell size distribution was analyzed us-
ing the Z2 AccuComp software (Beckman-Coulter).6xHIS tagging of SWI6 was done by plasmid integration. The WHI5
ORF was cloned by PCR into the pCR 2.1-TOPO vector (Invitrogen).
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